Current Perspectives on the Selective Regulation of Dopamine D2 and D3 Receptors

다국어 초록 (Multilingual Abstract)

Among the characterized dopamine receptor subtypes, D2 receptor (D2R) and D3 receptor (D3R) are the main targets of neuroleptics that are currently in use. In particular, D3R is closely related to the etiology of schizophrenia and drug addiction. The spatial expression patterns of D2R and D3R are distinct in certain areas of the brain. D2R are heavily expressed in the regions responsible for motor functions, whereas D3R are more selectively expressed in the limbic regions, which are associated with cognitive and emotional functions. Therefore, disturbances in the motor and endocrine functions, which are the most serious problems caused by the current neuroleptics, are likely to result from the non-selective blockade of D2R. Selective regulation of D3R is needed to separate the desired therapeutic activities from unwanted side effects that result from promiscuous blockade of other receptors. D2R and D3R possess high sequence homology and employ similar signaling pathways, and it is difficult to selectively regulate them. In this review, we discuss the signaling mechanisms, intracellular trafficking, and desensitization properties of D2R and D3R. In addition, the proteins interacting with D2R or D3R are discussed in relation to their roles in the regulation of receptor functions, followed by the current status of the development of selective D3R ligands.

참고문헌 (Reference)

• 1 Lohse, M. J, "beta-Arrestin: a protein that regulates beta-adrenergic receptor function" 248 : 1547-1550, 1990
• 2 Westrich, L, "The tolerance property of human D3 dopamine receptor is determined by specific amino acid residues in the second cytoplasmic loop" 1773 : 1747-1758, 2007
• 3 Takei, K, "The synaptic vesicle cycle: a single vesicle budding step involving clathrin and dynamin" 133 : 1237-1250, 1996
• 4 Boeckler, F, "The structural evolution of dopamine D3 receptor ligands: structure-activity relationships and selected neuropharmacological aspects" 112 : 281-333, 2006
• 5 Krueger, K. M, "The role of sequestration in G protein-coupled receptor resensitization. Regulation of beta2-adrenergic receptor dephosphorylation by vesicular acidification" 272 : 5-8, 1997
• 6 Scheideler, M. A, "The preferential dopamine D3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brain" 339 : 261-270, 1997
• 7 Guo, W, "The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer" 278 : 4385-4388, 2003
• 8 Gupta, S. K, "The effect of dopamine D1 and D2 receptor agonists on inositol phosphate turnover in rat striatal slices" 22 : 887-894, 1990
• 9 Waters, N, "The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity" 94 : 11-19, 1993
• 10 Dal Toso, R, "The dopamine D2 receptor: two molecular forms generated by alternative splicing" 8 : 4025-4034, 1989
• 11 Barak, L. S, "The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta 2-adrenergic receptor" 34 : 15407-15414, 1995
• 12 Laporte, S. A, "The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis" 96 : 3712-3717, 1999
• 13 Senogles, S. E, "The D2s dopamine receptor stimulates phospholipase D activity: a novel signaling pathway for dopamine" 58 : 455-462, 2000
• 14 Zhang, L. J, "The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells" 45 : 878-889, 1994
• 15 Brown, J. H, "Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3':5'-cyclic monophosphate formation in intact retina" 69 : 539-543, 1972
• 16 Seabrook, G. R, "Stable expression of human D3 dopamine receptors in GH4C1 pituitary cells" 312 : 123-126, 1992
• 17 Giros, B, "Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing" 176 : 1584-1592, 1991
• 18 Robinson, S. W, "Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor" 52 : 508-514, 1997
• 19 Millan, M. J, "Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis" 100 : 1047-1061, 2007
• 20 Millan, M. J, "S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats" 260 : R3-5, 1994
• 21 Cho, E. Y, "Roles of protein kinase C and actin-binding protein 280 in the regulation of intracellular trafficking of dopamine D3 receptor" 21 : 2242-2254, 2007
• 22 Quan, W, "Roles of G protein and beta-arrestin in dopamine D2 receptor-mediated ERK activation. Biochem. Biophys" 377 : 705-709, 2008
• 23 Eun-Young Cho, "Roles of Conserved Intracellular Sequences Regions for the Proper Expression of Dopamine D2 and D3 Receptors" 대한약학회 31 (31): 634-639, 2008
• 24 Ferguson, S. S, "Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization" 271 : 363-366, 1996
• 25 Ivins, K. J, "Regulation of dopamine D2 receptors in a novel cell line (SUP1)" 39 : 531-539, 1991
• 26 Binda, A. V, "Regulation of dense core vesicle release from PC12 cells by interaction between the D2 dopamine receptor and calcium-dependent activator protein for secretion (CAPS)" 69 : 1451-1461, 2005
• 27 Lee, T, "Receptor basis for dopaminergic supersensitivity in Parkinson's disease" 273 : 59-61, 1978
• 28 Namkung, Y, "Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor" 279 : 49533-49541, 2004
• 29 Lundstrom, K, "Proposed schizophreniarelated gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system" 225 : 1068-1072, 1996
• 30 Jung, M. Y, "Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors" 91 : 911-924, 1999
• 31 Kelly, M. A, "Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice" 19 : 103-113, 1997
• 32 Holmes, A, "Phenotypic analysis of dopamine receptor knockout mice; recent insights into the functional specificity of dopamine receptor subtypes" 47 : 1117-1134, 2004
• 33 Damsma, G, "Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand" 249 : R9-10, 1993
• 34 Baik, J. H, "Parkinsonianlike locomotor impairment in mice lacking dopamine D2 receptors" 377 : 424-428, 1995
• 35 Basile, M, "Paralemmin interacts with D3 dopamine receptors: implications for membrane localization and cAMP signaling" 446 : 60-68, 2006
• 36 Liu, Y, "Novel interaction of the dopamine D2 receptor and the Ca2+ binding protein S100B: role in D2 receptor function" 74 : 371-378, 2008
• 37 Anderson, D. W, "Neuroprotective effects of pramipexole in young and aged MPTP-treated mice" 905 : 44-53, 2001
• 38 Kebabian, J. W, "Multiple receptors for dopamine" 277 : 93-96, 1979
• 39 Ganz, M. B, "Multiple receptors coupled to adenylate cyclase regulate Na-H exchange independent of cAMP" 265 : 8989-8992, 1990
• 40 Monsma, F. J., Jr, "Multiple D2 dopamine receptors produced by alternative RNA splicing" 342 : 926-929, 1989
• 41 Dearry, A, "Molecular cloning and expression of the gene for a human D1 dopamine receptor" 347 : 72-76, 1990
• 42 Sokoloff, P, "Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics" 347 : 146-151, 1990
• 43 Li, M, "Modulation of dopamine D(2) receptor signaling by actin-binding protein (ABP-280)" 57 : 446-452, 2000
• 44 Caine, S. B, "Modulation of cocaine self-administration in the rat through D-3 dopamine receptors" 260 : 1814-1816, 1993
• 45 Liu, X. Y, "Modulation of D2R-NR2B interactions in response to cocaine" 52 : 897-909, 2006
• 46 Cunnah, D, "Management of prolactinomas" 34 : 231-235, 1991
• 47 Beaulieu, J. M, "Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade" 101 : 5099-5104, 2004
• 48 Lucotte, G, "Linkage with the Ser9Gly DRD3 polymorphism in essential tremor families" 69 : 437-440, 2006
• 49 Jeanneteau, F, "Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors" 15 : 696-705, 2004
• 50 Hannan, M. A, "Interaction with dopamine D2 receptor enhances expression of transient receptor potential channel 1 at the cell surface" 1778 : 974-982, 2008
• 51 Simmonds, S. H, "Inhibition of inositol phospholipid breakdown by D2 dopamine receptors in dissociated bovine anterior pituitary cells" 60 : 267-272, 1985
• 52 Levesque, D, "Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin" 89 : 8155-8159, 1992
• 53 Shpetner, H. S, "Identification of dynamin,a novel mechanochemical enzyme that mediates interactions between microtubules" 59 : 421-432, 1989
• 54 Sunahara, R. K, "Human dopamine D1 receptor encoded by an intronless gene on chromosome 5" 347 : 80-83, 1990
• 55 Cussac, D, "Human dopamine D(3) receptors mediate mitogenactivated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase Cdependent mechanism" 56 : 1025-1030, 1999
• 56 Hammond, S. M, "Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family" 270 : 29640-29643, 1995
• 57 Hasbi, A, "Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms" 10 : 99-, 2010
• 58 Shioda, N, "Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain" 30 : 3146-3155, 2010
• 59 Giros, B, "Gene cloning of human dopaminergic D3 receptor and identification of its chromosome" 311 : 501-508, 1990
• 60 Jeanneteau, F, "GIPC recruits GAIP (RGS19) to attenuate dopamine D2 receptor signaling" 15 : 4926-4937, 2004
• 61 Kim, K. M, "G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation" 280 : 12774-12780, 2005
• 62 Ferguson, S. S, "G protein-coupled receptor adaptation mechanisms" 9 : 119-127, 1998
• 63 Chen, C. H, "Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia" 74 : 40-43, 1997
• 64 Benovic, J. L, "Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein)" 84 : 8879-8882, 1987
• 65 Pilon, C, "Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line" 268 : 129-139, 1994
• 66 Freedman, S. B, "Expression and pharmacological characterization of the human D3 dopamine receptor" 268 : 417-426, 1994
• 67 Liu, Y, "Evidence that calmodulin binding to the dopamine D2 receptor enhances receptor signaling" 27 : 47-65, 2007
• 68 Olson, J. K, "Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail" 71 : 4042-4054, 1997
• 69 Gyertyan, I, "Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active,selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse" 320 : 1268-1278, 2007
• 70 Hinshaw, J. E, "Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding" 374 : 190-192, 1995
• 71 Starr, S, "Drug-induced upregulation of dopamine D2 receptors on cultured cells" 65 : 569-577, 1995
• 72 Bartlett, S. E, "Dopamine responsiveness is regulated by targeted sorting of D2 receptors" 102 : 11521-11526, 2005
• 73 Seeman, P, "Dopamine receptors and the dopamine hypothesis of schizophrenia" 1 : 133-152, 1987
• 74 Serretti, A, "Dopamine receptor D2 Ser/Cys311 variant associated with disorganized symptomatology of schizophrenia" 34 : 207-210, 1998
• 75 De Camilli, P, "Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas" 278 : 252-254, 1979
• 76 Joseph, J. D, "Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3)receptors" 112 : 39-49, 2002
• 77 Schneider, C. S, "Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analogue of apomorphine" 30 : 494-498, 1987
• 78 Diaz, J, "Dopamine D3 receptors expressed by all mesencephalic dopamine neurons" 20 : 8677-8684, 2000
• 79 Schwartz, J. C, "Dopamine D3 receptor: basic and clinical aspects" 16 : 295-314, 1993
• 80 Newman, A. H, "Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents" 48 : 3663-3679, 2005
• 81 Xu, M, "Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors" 19 : 837-848, 1997
• 82 Boeckler, F, "Dopamine D3 receptor ligands:recent advances in the control of subtype selectivity and intrinsic activity" 1768 : 871-887, 2007
• 83 Hackling, A. E, "Dopamine D3 receptor ligands with antagonist properties" 3 : 946-961, 2002
• 84 Joyce, J. N, "Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs" 90 : 231-259, 2001
• 85 Joyce, J. N, "Dopamine D3 receptor antagonists as therapeutic agents" 10 : 917-925, 2005
• 86 Neve, K. A, "Dopamine D2 receptor stimulation of Na+/H+ exchange assessed by quantification of extracellular acidification" 267 : 25748-25753, 1992
• 87 Pizzi, M, "Dopamine D2 receptor stimulation decreases the inositol trisphosphate level of rat striatal slices" 136 : 263-264, 1987
• 88 Tang, L, "Dopamine D2 and D3 receptors inhibit dopamine release" 270 : 475-479, 1994
• 89 Lin, R, "Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A" 98 : 5258-5263, 2001
• 90 Lee, S. P, "Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal" 279 : 35671-35678, 2004
• 91 Haadsma-Svensson, S. R, "Dopamine D(3) receptor antagonists. 1.Synthesis and structure-activity elationships of 5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindans" 44 : 4716-4732, 2001
• 92 Gurevich, E. V, "Distribution of dopamine D3 receptor expressing neurons in the human forebrain:comparison with D2 receptor expressing neurons" 20 : 60-80, 1999
• 93 Kim, S. J, "Distinct regulation of internalization and mitogen-activated protein kinase activation by two isoforms of the dopamine D2 receptor" 18 : 640-652, 2004
• 94 Usiello, A, "Distinct functions of the two isoforms of dopamine D2 receptors" 408 : 199-203, 2000
• 95 Vickery, R. G, "Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes" 144 : 31-43, 1999
• 96 Cho, D. I, "Direct and biochemical interaction between dopamine D3 receptor and elongation factor-1Bbetagamma" 73 : 2991-3004, 2003
• 97 Takeuchi, Y, "Differential subcellular localization of two dopamine D2 receptor isoforms in transfected NG108-15 cells" 85 : 1064-1074, 2003
• 98 Kim, K. M, "Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins" 276 : 37409-37414, 2001
• 99 Vallar, L, "Differential coupling of dopaminergic D2 receptors expressed in different cell types.Stimulation of phosphatidylinositol 4,5-bisphosphate hydrolysis in LtK- fibroblasts, hyperpolarization, and cytosolic-free Ca2+ concentration decrease in GH4C1 cells" 265 : 10320-10326, 1990
• 100 Stemp, G, "Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS pene tration in the rat" 43 : 1878-1885, 2000
• 101 Everett, P. B, "D3 dopamine receptor signals to activation of phospholipase D through a complex with Rho" 112 : 963-971, 2010
• 102 Everett, P. B, "D3 dopamine receptor activates phospholipase D through a pertussis toxin-insensitive pathway" 371 : 34-39, 2004
• 103 Senogles, S. E, "D2s dopamine receptor mediates phospholipase D and antiproliferation" 209 : 61-69, 2003
• 104 Kim, O. J, "D2 dopamine receptor expression and trafficking is regulated through direct interactions with ZIP" 106 : 83-95, 2008
• 105 Binda, A. V, "D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N" 62 : 507-513, 2002
• 106 Heidbreder, C. A, "Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders" 1187 : 4-34, 2010
• 107 Kim, K. M, "Complementary roles of the DRY motif and C-terminus tail of GPCRS for G protein coupling and beta-arrestin interaction" 366 : 42-47, 2008
• 108 Beom, S, "Comparative studies of molecular mechanisms of dopamine D2 and D3 receptors for the activation of extracellular signal-regulated kinase" 279 : 28304-28314, 2004
• 109 Kodaki, T, "Cloning, expression, and characterization of a novel phospholipase D complementary DNA from rat brain" 272 : 11408-11413, 1997
• 110 Sunahara, R. K, "Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1" 350 : 614-619, 1991
• 111 Van Tol, H. H, "Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine" 350 : 610-614, 1991
• 112 Bunzow, J. R, "Cloning and expression of a rat D2 dopamine receptor cDNA" 336 : 783-787, 1988
• 113 Robinson, S. W, "Chimeric D2/D3 dopamine receptors efficiently inhibit adenylyl cyclase in HEK 293 cells" 67 : 212-219, 1996
• 114 Hammond, S. M, "Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate,ADP-ribosylation factor, and Rho family monomeric GTPbinding proteins and protein kinase C-alpha" 272 : 3860-3868, 1997
• 115 Cho, D. I, "Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptors" 350 : 634-640, 2006
• 116 Wade, T. V, "Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism" 905 : 111-119, 2001
• 117 Bofill-Cardona, E, "Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch" 275 : 32672-32680, 2000
• 118 DeWire, S. M, "Beta-arrestins and cell signaling" 69 : 483-510, 2007
• 119 Benovic, J. L, "Beta-adrenergic receptor kinase: primary structure delineates a multigene family" 246 : 235-240, 1989
• 120 Daly, S. A, "Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other D-2-like agonists" 32 : 509-510, 1993
• 121 Svensson, K, "Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors" 263 : 235-243, 1994
• 122 Boeckler, F, "Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice" 66 : 1025-1032, 2003
• 123 Smith, F. D, "Association of the D2 dopamine receptor third cytoplasmic loop with spinophilin, a protein phosphatase-1-interacting protein" 274 : 19894-19900, 1999
• 124 Li, M, "Association of dopamine D(3) receptors with actin-binding protein 280 (ABP-280)" 63 : 859-863, 2002
• 125 Kovacs, J. J, "Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways" 17 : 443-458, 2009
• 126 Kabbani, N, "Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex" 17 : 299-301, 2006
• 127 Lenz, C, "Analogues of FAUC 73 revealing new insights into the structural requirements of nonaromatic dopamine D3 receptor gonists" 12 : 113-117, 2004
• 128 Lan, H, "An intracellular loop 2 amino acid residue determines differential binding of arrestin to the dopamine D2 and D3 receptors" 75 : 19-26, 2009
• 129 Beaulieu, J. M, "An Akt/betaarrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior" 122 : 261 - 273, 2005
• 130 Lannfelt, L, "Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders" 2 : 249-256, 1992
• 131 Giros, B, "Alternative splicing directs the expression of two D2 dopamine receptor isoforms" 342 : 923-926, 1989
• 132 Koeltzow, T. E, "Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice" 18 : 2231-2238, 1998
• 133 Cho, D. I, "Agonist-induced endocytosis and receptor phosphorylation mediate resensitization of dopamine D(2) receptors" 24 : 574-586, 2010
• 134 Liu, X. Y, "Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII" 61 : 425-438, 2009
• 135 Takeuchi, Y, "Activation of the rat dopamine D2 receptor promoter by mitogenactivated protein kinase and Ca2+/calmodulin-dependent protein kinase II pathways" 83 : 784-796, 2002
• 136 Takeuchi, Y, "Activation of nuclear Ca(2+)/calmodulin-dependent protein kinase II and brain-derived neurotrophic factor gene expression by stimulation of dopamine D2 receptor in transfected NG108-15 cells" 82 : 316-328, 2002
• 137 Kuzhikandathil, E. V, "Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells" 19 : 1698-1707, 1999
• 138 Chio, C. L, "Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors" 45 : 51-60, 1994
• 139 Accili, D, "A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice" 93 : 1945-1949, 1996
• 140 Itokawa, M, "A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys). Biochem. Biophys" 196 : 1369-1375, 1993
• 141 Fishburn, C. S, "A novel short isoform of the D3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop" 268 : 5872-5878, 1993
• 142 Walensky, L. D, "A novel neuron-enriched homolog of the erythrocyte membrane cytoskeletal protein 4.1" 19 : 6457-6467, 1999
• 143 Goldman, D, "A functionally deficient DRD2 variant [Ser311Cys]is not linked to alcoholism and substance abuse" 16 : 47-52, 1998
• 144 Jeanneteau, F, "A functional variant of the dopamine D3 receptor is associated with risk and ageat-onset of essential tremor" 103 : 10753-10758, 2006
• 145 Walaas, S. I, "A dopamineand cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions" 301 : 69-71, 1983
• 146 Lan, H, "A dopamine D2 receptor mutant capable of G proteinmediated signaling but deficient in arrestin binding" 75 : 113-123, 2009
• 147 Beaulieu, J. M, "A beta-arrestin 2 signaling complex mediates lithium action on behavior" 132 : 125-136, 2008
• 148 Carlsson, A, "3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists" 180 : 1200-, 1957